Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants

BACKGROUND: Trivalent inactivated influenza vaccine (TIV) is not licensed for use in infants <6 months old, the group with the highest influenza hospitalization rates among children. METHODS: In this prospective, open-label study, 2 doses of TIV were administered to healthy infants aged 10–22 wee...

Full description

Saved in:
Bibliographic Details
Main Authors: Halasa, Natasha B., Gerber, Michael A., Chen, Qingxia, Wright, Peter F., Edwards, Kathryn M.
Format: Artigo
Language:Inglês
Published: 2008
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3773726/
https://ncbi.nlm.nih.gov/pubmed/18444800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/587643
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items